COVID-19
Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2
June 16, 2020Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma
As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …
FDA revokes emergency approval of hydroxychloroquine and chloroquine
June 16, 2020Manufacturing and Production COVID-19, chloroquine, coronavirus, hydroxychloroquine
The FDA has revoked its emergency approval of hydroxychloroquine and chloroquine due to health risks and a lack of effectiveness …
COVID-19: UK and Europe life sciences regulatory developments
June 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation
Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …
Fear of a coronavirus second wave as China reports highest number of cases in months
June 15, 2020Sales and Marketing COVID, COVID-19, coronavirus, pandemic
China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …
AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses
June 15, 2020Sales and Marketing COVID, COVID-19, Vaccine, coronavirus
Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …
Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July
June 12, 2020Medical Communications COVID-19, coronavirus
Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials. The …
Coronavirus has caused widespread disruption to cancer care in England
June 12, 2020Medical Communications COVID-19, coronavirus
Figures show that cancer care in England has faced major disruption due to a big drop in referrals from GPs …
Eli Lilly’s coronavirus antibody treatments could be available by September
June 11, 2020Business Services COVID, COVID-19, coronavirus
An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its …
Number of people waiting for NHS treatment could double to 10 million due to pandemic
June 10, 2020Research and Development COVID-19, coronavirus
The backlog of people waiting for treatment on the NHS could reach as high as 10 million people by Christmas …
Pharmafile.com’s weekly COVID-19 news round-up
June 10, 2020Research and Development COVID-19, coronavirus, round up, top 10
Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at …
US trial of ivermectin cuts coronavirus mortality by 40%
June 10, 2020Research and Development COVID-19, coronavirus
A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%. …
EMA could approve Gilead’s streamlined remdesivir application for COVID-19 “within weeks”
June 9, 2020Manufacturing and Production, Sales and Marketing COVID-19, EU, Gilead, coronavirus, remdesivir
The European Medicines Agency has received the application from Gilead for the first conditional marketing authorisation (CMA) of its antiviral …
Coronavirus lockdowns prevented 3.1 million deaths throughout Europe, according to new study
June 9, 2020Manufacturing and Production COVID-19, coronavirus, pandemic
The widespread lockdowns implemented throughout Europe are estimated to have prevented 3.1 million deaths from the COVID-19 pandemic. This is …
COVID-19 could have emerged in Wuhan as early as August, new study speculates
June 9, 2020Manufacturing and Production COVID-19, Wuhan, coronavirus
Coronavirus may have been spreading throughout Wuhan in August 2019, according to a new study. This research was carried out …
AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients
June 8, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma
AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
